A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]

NCT07111546 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumour

Interventions

DRUG: LBL-024 for Injection
DRUG: Cisplatin Injection
DRUG: Gemcitabine Hydrochloride for Injection
DRUG: Bevacizumab Injection

Sponsor

Nanjing Leads Biolabs Co.,Ltd

Collaborators

[object Object]